Navigation Links
Drug for pediatric brain cancer

Scientists from Canada are reporting promising results from a study of a new drug for children with acute brain tumors. The drug fotemustine, when delivered intravenously every three weeks, was found to be partially effective in shrinking the tumors.
//
The drug is one of a group of drugs called chloroethylnitrosoureas. They were first discovered in 1959 and have since been shown to help shrink solid tumors, including cancerous brain tumors. Studies in adults with brain tumors showed fotemustine was at least partially effective in about 20 percent of patients.

In this study, researchers from the Hospital for Sick Children in Toronto tested the drug in 14 children under age 20 with various types of malignant brain tumors, including primary tumors and tumors caused by cancer that had spread to the brain. All of the children had exhausted conventional.

Together the children received a total of 40 doses of the medication. Images were then taken to measure the response to the drug. Three children demonstrated a positive response to the drug, with one showing a 50 percent or greater reduction in the tumor and the other two showing 25% to 50% reductions. The drug was generally well-tolerated by the children.

The researchers believe these results indicate a need for further study of fotemustine for the treatment of pediatric brain tumors and suggest the need for more studies involving the drug alone or possibly in combination with other agents.


'"/>




Page: 1

Related medicine news :

1. Medicis Pharmaceutical company enters pediatric market
2. Drug for pediatric brain cancer
3. Lorenzos oil for prevention of pediatric neurological disorder
4. British pediatricians urge parents to administer MMR to children
5. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
6. Two doctors suspended for wrong brain surgery
7. The brain loves a surprise
8. Increase in sugar...decrease in brain function!!!
9. Alcohol shrinks brain
10. Roller coaster takes brain for a big ride!!
11. The big brain in suicides
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... ... January 24, 2017 , ... In comments ... Research Institute (PCORI) for developing a data access and sharing policy. The nation’s ... data sharing plan as part of award applications, and earmarking specified amounts of ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... introduces more changes during the Annual Enrollment Period (AEP) and the Open Enrollment ... looking for health insurance coverage. Mainly, people are witnessing higher deductibles, rising premiums, ...
(Date:1/24/2017)... ... January 24, 2017 , ... PeroxyChem Food and ... Control Equipment (PACE), at the International Production and Processing Expo (IPPE) in Atlanta, ... the new technology that is used in poultry processing facilities to provide constant, ...
(Date:1/24/2017)... , ... January 24, 2017 , ... ... “Lacto-Freedom” was recently accepted as a Registered Trademark by the United States Patent ... using a similar name which could confuse consumers into thinking that other products ...
(Date:1/24/2017)... Estates, CA (PRWEB) , ... January 24, 2017 , ... ... at studies, work, athletics or even in relationships. Course offered by Dr. Carol ... is necessary due to limited seating and the many hands-on experiences. , ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... , Jan. 24, 2017   Intrexon Corporation ... and industrialization of biology to improve the quality of life ... entered into a definitive agreement to acquire GenVec, Inc ... pioneer in the development of AdenoVerse™ gene delivery technology.  ... expertise in adenoviral vectors and cGMP drug product manufacturing to ...
(Date:1/24/2017)... 24, 2017   Keneric Healthcare , a ... effective patient care products, today announced their partnership ... the reach of both companies by leveraging their ... Angelini Pharma Inc . ... include Keneric Healthcare,s RTD™ Wound Dressing (antibacterial/antifungal).  RTD™ ...
(Date:1/24/2017)... 2017 Stock-Callers.com today has issued research ... ZTS ), Mallinckrodt PLC (NYSE: MNK ), ... Inc. (NYSE: DPLO ). According to pharmaceutical manufacturer ... 2017 for the Generic Drugs industry, including a possible reduction ... current growth, and a speedier FDA approval process that could ...
Breaking Medicine Technology: